Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome

NCT03188068 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT03188068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2017
Completion date
December 31, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kaposiform hemangioendothelioma, kasabach merritt phenomenon